Australia's approach to newborn diagnostic testing seems very confusing. One reason cited in rejecting Pompe was the risk of 'hypervigilant' parents. Pompe is a degenerative condition where early diagnosis and treatment are critical. Yet some state-based research programs are testing for inherited high cholesterol. …
Research trials screen babies for hundreds of conditions while existing programs can't all add one
September 30, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The regulator that deleted the truth from its answers now wants to police the media
October 1, 2026 - - Latest News -
By the TGA's own test, the Health Minister's press releases are advertising
October 1, 2026 - - Latest News -
Eczema patients who don't respond to steroids get subsidised access to ointment
October 1, 2026 - - Latest News -
Vitrafy takes its frozen platelet push to America's Midwest
September 30, 2026 - - Australian Biotech -
Paradigm Biopharmaceuticals enters voluntary administration after Phase 3 setback
September 30, 2026 - - Australian Biotech -
FDA fast tracks Telix scan that could spare men prostate biopsies
September 30, 2026 - - Australian Biotech -
Australian broadcast personality reveals the scars shingles left behind
September 30, 2026 - - Latest News